36C24819R0003-0001001.xlsx
XLSX spreadsheet 283 KB Posted
- Solicitation number
- 36C24819R0003
About this file
This document provides a pre-solicitation notice for a request for proposal for whole blood and blood products for the Department of Veterans Affairs Veterans Integrated Service Network 8. The notice identifies a planned firm-fixed price indefinite delivery, indefinite quantity contract for a base period of 12 months with four 12-month options to be awarded to a single vendor for supply of products to six VA medical centers located in Florida, Puerto Rico, and Tampa. Interested vendors are directed to submit any questions by a specified date in October 2018 in preparation for the anticipated RFP release on October 12, 2018.
36C24819R0003 0001 ATTACHMENT A PRICE_COST SCHEDULE 5 Yr Ordering All Sites.xlsx
View the file
Other files
| File | Type | Posted |
|---|---|---|
| 36C24819R0003_0002.docx | DOCX document | |
| Answers_to_Questions_VISN_8_Solicitation_36C24819R0003.pdf | ||
| 36C24819R0003-0001000.docx | DOCX document | |
| 36C24819R0003-003.xlsx | XLSX spreadsheet | |
| 36C24819R0003-001.docx | DOCX document | |
| 36C24819R0003-002.docx | DOCX document | |
| 36C24819R0003-000.docx | DOCX document |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Bay Pines
| ATTACHMENT A: PRICE/COST SCHEDULE - BAY PINES | ||||||
| Bay Pines VA Healthcare System, 10000 Bay Pines Blvd, Bay Pines, FL 33744 | ||||||
| BASE PERIOD (Estimated Delivery date January 1, 2019 - September 30, 2019 | ||||||
| BLOOD COMPONENTS | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Est Unit Price | Estimated Total Price | |
| 0001 | Whole Blood Leukoreduced | 1 | EA | $ - 0 | ||
| 0002 | Whole Blood Leukoreduced Low | |||||
| Volume | 1 | EA | $ - 0 | |||
| 0003 | Whole Blood Leukoreduced Low | |||||
| Volume Irradiated | 1 | EA | $ - 0 | |||
| 0004 | Whole Blood Autologous | |||||
| Leukoreduced | 1 | EA | $ - 0 | |||
| 0005 | Red Blood Cells Leukoreduced | 2348 | EA | $ - 0 | ||
| 0006 | Red Blood Cells Leukoreduced | |||||
| Deglycerolized | 1 | EA | $ - 0 | |||
| 0007 | Red Blood Cells Leukoreduced Frozen | 1 | EA | $ - 0 | ||
| 0008 | Red Blood Cells Leukoreduced | |||||
| Irradiated | 1 | EA | $ - 0 | |||
| 0009 | Red Blood Cells Leukoreduced Low | |||||
| Volume | 1 | EA | $ - 0 | |||
| 0010 | Red Blood Cells Leukoreduced Washed | 1 | EA | $ - 0 | ||
| 0011 | Red Blood Cells Leukoreduced | |||||
| Deglycerolized Irradiated | 1 | EA | $ - 0 | |||
| 0012 | Red Blood Cells Leukoreduced | |||||
| Irradiated Washed | 1 | EA | $ - 0 | |||
| 0013 | Red Blood Cells Leukoreduced Processing ‐ Infant (PediCells ‐ CMV | |||||
| Neg.,) | 1 | EA | $ - 0 | |||
| 0014 | Red Blood Cells Autologous | |||||
| Leukoreduced | 1 | EA | $ - 0 | |||
| 0015 | Red Blood Cells Autologous | |||||
| Leukoreduced Deglycerolized | 1 | EA | $ - 0 | |||
| 0016 | Whole Blood Platelets Leukoreduced | 1 | EA | $ - 0 | ||
| 0017 | Platelet Pheresis Pedi‐D | 1 | EA | $ - 0 | ||
| 0018 | Platelet Pheresis Pedi‐W | 1 | EA | $ - 0 | ||
| 0019 | Cryoprecipitate | 1 | EA | $ - 0 | ||
| 0020 | Pooled Cryoprecipitate (5) | 1 | EA | $ - 0 | ||
| 0021 | Pooled Cryoprecipitate (10) | 15 | EA | $ - 0 | ||
| 0022 | Fresh Frozen Plasma | 423 | EA | $ - 0 | ||
| 0023 | Fresh Frozen Plasma Cryo‐removed | 1 | EA | $ - 0 | ||
| 0024 | Fresh Frozen Plasma 0‐24 | 1 | EA | $ - 0 | ||
| 0025 | Fresh Frozen Plasma ‐ Infant Dose | |||||
| (Pediplasma Processing) | 1 | EA | $ - 0 | |||
| 0026 | Neo‐Natal Fresh Frozen Plasma | 1 | EA | $ - 0 | ||
| 0027 | Plasma (Liquid) | 1 | EA | $ - 0 | ||
| 0028 | Plasma (Liquid) Irradiated | 1 | EA | $ - 0 | ||
| 0029 | Source Leukocyte | 1 | EA | $ - 0 | ||
| 0030 | Apheresis Platelets (SDP) | |||||
| Leukoreduced | 343 | EA | $ - 0 | |||
| 0031 | Apheresis Platelets (SDP) | |||||
| Leukoreduced Irradiated | 1 | EA | $ - 0 | |||
| 0032 | Apheresis Platelets (SDP) | |||||
| Leukoreduced Low Volume | 1 | EA | $ - 0 | |||
| 0033 | Apheresis Platelets (SDP)/LIW Leukoreduced Irradiated Washed | 1 | EA | $ - 0 | ||
| 0034 | Apheresis Platelets (SDP) | |||||
| Leukoreduced Low Volume Irradiated | 1 | EA | $ - 0 | |||
| 0035 | Apheresis Platelets (SDP) Autologous | |||||
| Leukoreduced Irradiated | 1 | EA | $ - 0 | |||
| 0036 | Apheresis Granulocytes | 1 | EA | $ - 0 | ||
| 0037 | Apheresis Granulocytes Irradiated | 1 | EA | $ - 0 | ||
| 0038 | Pooled Platelets Leukoreduced | 1 | EA | $ - 0 | ||
| 0039 | Pooled Platelets Leukoreduced | |||||
| Irradiated | 1 | EA | $ - 0 | |||
| SUBTOTAL | $ - 0 | |||||
| CELLULAR LAB | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 0040 | SC ABO Incompatible Buffy Coat Enrichment | 1 | EA | $ - 0 | ||
| 0041 | SC Plasma Depletion | 1 | EA | $ - 0 | ||
| 0042 | SC Cryopreservation (includes 1st year storage) | 1 | EA | $ - 0 | ||
| 0043 | SC Colony Forming Unit (CFU) | 1 | EA | $ - 0 | ||
| 0044 | SC Stem Cell Quality Control | 1 | EA | $ - 0 | ||
| 0045 | SC Cord Wash Process | 1 | EA | $ - 0 | ||
| 0046 | SC Cord Blood Reconstitution | 1 | EA | $ - 0 | ||
| 0047 | Stem Cell Freight | 1 | EA | $ - 0 | ||
| 0048 | SC Thawing Frozen Cell (QC Vial ea) | 1 | EA | $ - 0 | ||
| 0049 | SC CBC with automated differential | 1 | EA | $ - 0 | ||
| 0050 | SC CBC with manual differential | 1 | EA | $ - 0 | ||
| 0051 | CD34 Test | 1 | EA | $ - 0 | ||
| 0052 | SC Cellular Night and Weekend Fee | 1 | EA | $ - 0 | ||
| 0053 | SC Trypan Blue viability | 1 | EA | $ - 0 | ||
| 0054 | SC Storage greater than 1 year (storage per year) | 1 | EA | $ - 0 | ||
| 0055 | SC Sterility Check | 1 | EA | $ - 0 | ||
| 0056 | SC CD3 | 1 | EA | $ - 0 | ||
| 0057 | SC CD4 | 1 | EA | $ - 0 | ||
| 0058 | SC CD8 | 1 | EA | $ - 0 | ||
| 0059 | SC Processing Split Exceeding 4 Bags (each) | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 | |||||
| HLA AND SPECIAL HEMATOLOGY TESTING | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 0060 | Platelet Crossmatch | 1 | EA | $ - 0 | ||
| 0061 | HLA/Platelet Antibody Screen (Serology/ELISA) | 1 | EA | $ - 0 | ||
| 0062 | HLA‐Antibody Intermediate Resolution, Complex | 1 | EA | $ - 0 | ||
| 0063 | Neonate Allo Thrombocytopenia Assessment | 1 | EA | $ - 0 | ||
| 0064 | Platelet Genotyping | 1 | EA | $ - 0 | ||
| 0065 | Platelet Auto Antibodies | 1 | EA | $ - 0 | ||
| 0066 | HLA ABC Typing (Class I) | 1 | EA | $ - 0 | ||
| 0067 | HLA DR/DQ Typing (Class II) | 1 | EA | $ - 0 | ||
| 0068 | HLA for Platelet Pheresis | 1 | EA | $ - 0 | ||
| 0069 | HLA‐Antibody Intermediate Resolution, Basic | 1 | EA | $ - 0 | ||
| 0070 | RBC Genotype Bioarray (HEA) | 1 | EA | $ - 0 | ||
| 0071 | HLA ‐ ABC/DR High Resolution, DQ Low Resolution | 1 | EA | $ - 0 | ||
| 0072 | Heparin Induced Thrombocytopenia Antibody (HIT) | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 | |||||
| APHERESIS AND THERAPEUTIC SERVICES | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 0073 | HPC Apheresis | 1 | EA | $ - 0 | ||
| 0074 | Photopheresis Procedure | 1 | EA | $ - 0 | ||
| 0075 | Therapeutic Cellular Depletion ‐ WBC | 1 | EA | $ - 0 | ||
| 0076 | Therapeutic Phlebotomy (In Blood | |||||
| Center) | 1 | EA | $ - 0 | |||
| 0077 | Therapeutic phlebotomy ‐ in hospital | 1 | EA | $ - 0 | ||
| 0078 | Therapeutic phlebotomy with | |||||
| replacement fluid ‐ in hospital | 1 | EA | $ - 0 | |||
| 0079 | Red Blood Cell Exchange | 1 | EA | $ - 0 | ||
| 0080 | Therapeutic Cellular Depletion ‐ RBC | 1 | EA | $ - 0 | ||
| 0081 | Therapeutic Cellular Depletion ‐ | |||||
| Platelet | 1 | EA | $ - 0 | |||
| 0082 | Therapeutic Plasma Exchange | 74 | EA | $ - 0 | ||
| 0083 | Red Cell Prime | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 | |||||
| REFERENCE TESTING | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 0084 | Radsure Label to be Irradiated | 1 | EA | $ - 0 | ||
| 0085 | Irradiation of Unit | 38 | EA | $ - 0 | ||
| 0086 | Deglycerolization of Unit | 1 | EA | $ - 0 | ||
| 0087 | Freeze Unit | 1 | EA | $ - 0 | ||
| 0088 | Freeze & Deglycerolization Unit | 1 | EA | $ - 0 | ||
| 0089 | Pooling unit(s) | 1 | EA | $ - 0 | ||
| 0090 | Thaw Unit | 1 | EA | $ - 0 | ||
| 0091 | RBC Wash | 1 | EA | $ - 0 | ||
| 0092 | Platelet Wash | 1 | EA | $ - 0 | ||
| 0093 | RBC Crossmatch (each additional unit) | 1 | EA | $ - 0 | ||
| 0094 | Non‐crossmatch set up | 1 | EA | $ - 0 | ||
| 0095 | ABO Group | 1 | EA | $ - 0 | ||
| 0096 | RH Type | 1 | EA | $ - 0 | ||
| 0097 | Chemical Treatment | 1 | EA | $ - 0 | ||
| 0098 | Aliquot Bag | 1 | EA | $ - 0 | ||
| 0099 | Confirmatory Draw | 1 | EA | $ - 0 | ||
| 0100 | Platelet (Volume Reduction Fee) | 1 | EA | $ - 0 | ||
| 0101 | Computer Antigen Search (per Antigen) | 1 | EA | $ - 0 | ||
| 0102 | Patient Complete Phenotype, Serologic | 1 | EA | $ - 0 | ||
| 0103 | Reconstitute | 1 | EA | $ - 0 | ||
| 0104 | RBC Antibody Identification | 30 | EA | $ - 0 | ||
| 0105 | Rare Unit | 5 | EA | $ - 0 | ||
| 0106 | Antigen Typing ‐ Single | 230 | EA | $ - 0 | ||
| 0107 | RBC Selected Cell Panel | 1 | EA | $ - 0 | ||
| 0108 | RBC Cell Separation | 1 | EA | $ - 0 | ||
| 0109 | IgG Dissociation | 1 | EA | $ - 0 | ||
| 0110 | Dithiotreitol Treatment | 1 | EA | $ - 0 | ||
| 0111 | Neutralization P1 or Lewis | 1 | EA | $ - 0 | ||
| 0112 | Chloroquine treatment | 1 | EA | $ - 0 | ||
| 0113 | Acid Elution / Cell Elution | 30 | EA | $ - 0 | ||
| 0114 | Donath‐Landsteiner Test | 1 | EA | $ - 0 | ||
| 0115 | Irradiation ‐ Per Random Platelet | 1 | EA | $ - 0 | ||
| 0116 | Rare Donor Search thru American Rare Donor Program (ARDP) | 1 | EA | $ - 0 | ||
| 0117 | Splitting Service | 1 | EA | $ - 0 | ||
| 0118 | Type and Screen | 30 | EA | $ - 0 | ||
| 0119 | ABO Group & Rh Type | 75 | EA | $ - 0 | ||
| 0120 | Antibody Screen (Indirect Coombs) | 15 | EA | $ - 0 | ||
| 0121 | RBC Antibody Titer | 1 | EA | $ - 0 | ||
| 0122 | Direct Antiglobulin IgG (Direct Coombs) | 63 | EA | $ - 0 | ||
| 0123 | Direct Antiglobulin DAT C3 | 1 | EA | $ - 0 | ||
| 0124 | Fetal Screen | 1 | EA | $ - 0 | ||
| 0125 | Kleihauer ‐ Betke | 1 | EA | $ - 0 | ||
| 0126 | CMV Test | 1 | EA | $ - 0 | ||
| 0127 | Sickle Cell Screen | 6 | EA | $ - 0 | ||
| 0128 | LUI Elution | 1 | EA | $ - 0 | ||
| 0129 | RBC Antibody Panel | 158 | EA | $ - 0 | ||
| 0130 | Transfusion Reaction Work Up | 5 | EA | $ - 0 | ||
| 0131 | RBC Antigen Typing | 32 | EA | $ - 0 | ||
| 0132 | Adsorption | 32 | EA | $ - 0 | ||
| 0133 | Cold Agglutinin Titer | 1 | EA | $ - 0 | ||
| 0134 | ABO RH Cord | 1 | EA | $ - 0 | ||
| 0135 | Sterile Doc Quad Pack | 1 | EA | $ - 0 | ||
| 0136 | Enzyme Treatment | 2 | EA | $ - 0 | ||
| 0137 | Lookback | 1 | EA | $ - 0 | ||
| 0138 | Crossmatch ‐ Electronic | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 | |||||
| OTHER TESTING | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 0139 | NAT (HIV ‐ I, HBV and HCV RNA) | |||||
| DONOR ONLY | 1 | EA | $ - 0 | |||
| 0140 | Non‐Donor Infectious Disease Markers 3327 | 1 | EA | $ - 0 | ||
| 0141 | Non‐Donor Infectious Disease Markers 3486, no ABO/Rh | 1 | EA | $ - 0 | ||
| 0142 | White Blood Cell Counts by Flow Cytometry | 1 | EA | $ - 0 | ||
| 0143 | Cryoprecipitate QC | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 |
TOTAL $ - 0
| OPTION PERIOD ONE (October 1, 2019 - September 30, 2020) | ||||||
| BLOOD COMPONENTS | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 1001 | Whole Blood Leukoreduced | 1 | EA | $ - 0 | ||
| 1002 | Whole Blood Leukoreduced Low | |||||
| Volume | 1 | EA | $ - 0 | |||
| 1003 | Whole Blood Leukoreduced Low | |||||
| Volume Irradiated | 1 | EA | $ - 0 | |||
| 1004 | Whole Blood Autologous | |||||
| Leukoreduced | 1 | EA | $ - 0 | |||
| 1005 | Red Blood Cells Leukoreduced | 2348 | EA | $ - 0 | ||
| 1006 | Red Blood Cells Leukoreduced | |||||
| Deglycerolized | 1 | EA | $ - 0 | |||
| 1007 | Red Blood Cells Leukoreduced Frozen | 1 | EA | $ - 0 | ||
| 1008 | Red Blood Cells Leukoreduced | |||||
| Irradiated | 1 | EA | $ - 0 | |||
| 1009 | Red Blood Cells Leukoreduced Low | |||||
| Volume | 1 | EA | $ - 0 | |||
| 1010 | Red Blood Cells Leukoreduced Washed | 1 | EA | $ - 0 | ||
| 1011 | Red Blood Cells Leukoreduced | |||||
| Deglycerolized Irradiated | 1 | EA | $ - 0 | |||
| 1012 | Red Blood Cells Leukoreduced | |||||
| Irradiated Washed | 1 | EA | $ - 0 | |||
| 1013 | Red Blood Cells Leukoreduced Processing ‐ Infant (PediCells ‐ CMV | |||||
| Neg.,) | 1 | EA | $ - 0 | |||
| 1014 | Red Blood Cells Autologous | |||||
| Leukoreduced | 1 | EA | $ - 0 | |||
| 1015 | Red Blood Cells Autologous | |||||
| Leukoreduced Deglycerolized | 1 | EA | $ - 0 | |||
| 1016 | Whole Blood Platelets Leukoreduced | 1 | EA | $ - 0 | ||
| 1017 | Platelet Pheresis Pedi‐D | 1 | EA | $ - 0 | ||
| 1018 | Platelet Pheresis Pedi‐W | 1 | EA | $ - 0 | ||
| 1019 | Cryoprecipitate | 1 | EA | $ - 0 | ||
| 1020 | Pooled Cryoprecipitate (5) | 1 | EA | $ - 0 | ||
| 1021 | Pooled Cryoprecipitate (10) | 15 | EA | $ - 0 | ||
| 1022 | Fresh Frozen Plasma | 423 | EA | $ - 0 | ||
| 1023 | Fresh Frozen Plasma Cryo‐removed | 1 | EA | $ - 0 | ||
| 1024 | Fresh Frozen Plasma 0‐24 | 1 | EA | $ - 0 | ||
| 1025 | Fresh Frozen Plasma ‐ Infant Dose | |||||
| (Pediplasma Processing) | 1 | EA | $ - 0 | |||
| 1026 | Neo‐Natal Fresh Frozen Plasma | 1 | EA | $ - 0 | ||
| 1027 | Plasma (Liquid) | 1 | EA | $ - 0 | ||
| 1028 | Plasma (Liquid) Irradiated | 1 | EA | $ - 0 | ||
| 1029 | Source Leukocyte | 1 | EA | $ - 0 | ||
| 1030 | Apheresis Platelets (SDP) | |||||
| Leukoreduced | 343 | EA | $ - 0 | |||
| 1031 | Apheresis Platelets (SDP) | |||||
| Leukoreduced Irradiated | 1 | EA | $ - 0 | |||
| 1032 | Apheresis Platelets (SDP) | |||||
| Leukoreduced Low Volume | 1 | EA | $ - 0 | |||
| 1033 | Apheresis Platelets (SDP)/LIW Leukoreduced Irradiated Washed | 1 | EA | $ - 0 | ||
| 1034 | Apheresis Platelets (SDP) | |||||
| Leukoreduced Low Volume Irradiated | 1 | EA | $ - 0 | |||
| 1035 | Apheresis Platelets (SDP) Autologous | |||||
| Leukoreduced Irradiated | 1 | EA | $ - 0 | |||
| 1036 | Apheresis Granulocytes | 1 | EA | $ - 0 | ||
| 1037 | Apheresis Granulocytes Irradiated | 1 | EA | $ - 0 | ||
| 1038 | Pooled Platelets Leukoreduced | 1 | EA | $ - 0 | ||
| 1039 | Pooled Platelets Leukoreduced | |||||
| Irradiated | 1 | EA | $ - 0 | |||
| SUBTOTAL | $ - 0 | |||||
| CELLULAR LAB | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 1040 | SC ABO Incompatible Buffy Coat Enrichment | 1 | EA | $ - 0 | ||
| 1041 | SC Plasma Depletion | 1 | EA | $ - 0 | ||
| 1042 | SC Cryopreservation (includes 1st year storage) | 1 | EA | $ - 0 | ||
| 1043 | SC Colony Forming Unit (CFU) | 1 | EA | $ - 0 | ||
| 1044 | SC Stem Cell Quality Control | 1 | EA | $ - 0 | ||
| 1045 | SC Cord Wash Process | 1 | EA | $ - 0 | ||
| 1046 | SC Cord Blood Reconstitution | 1 | EA | $ - 0 | ||
| 1047 | Stem Cell Freight | 1 | EA | $ - 0 | ||
| 1048 | SC Thawing Frozen Cell (QC Vial ea) | 1 | EA | $ - 0 | ||
| 1049 | SC CBC with automated differential | 1 | EA | $ - 0 | ||
| 1050 | SC CBC with manual differential | 1 | EA | $ - 0 | ||
| 1051 | CD34 Test | 1 | EA | $ - 0 | ||
| 1052 | SC Cellular Night and Weekend Fee | 1 | EA | $ - 0 | ||
| 1053 | SC Trypan Blue viability | 1 | EA | $ - 0 | ||
| 1054 | SC Storage greater than 1 year (storage per year) | 1 | EA | $ - 0 | ||
| 1055 | SC Sterility Check | 1 | EA | $ - 0 | ||
| 1056 | SC CD3 | 1 | EA | $ - 0 | ||
| 1057 | SC CD4 | 1 | EA | $ - 0 | ||
| 1058 | SC CD8 | 1 | EA | $ - 0 | ||
| 1059 | SC Processing Split Exceeding 4 Bags (each) | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 | |||||
| HLA AND SPECIAL HEMATOLOGY TESTING | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 1060 | Platelet Crossmatch | 1 | EA | $ - 0 | ||
| 1061 | HLA/Platelet Antibody Screen (Serology/ELISA) | 1 | EA | $ - 0 | ||
| 1062 | HLA‐Antibody Intermediate Resolution, Complex | 1 | EA | $ - 0 | ||
| 1063 | Neonate Allo Thrombocytopenia Assessment | 1 | EA | $ - 0 | ||
| 1064 | Platelet Genotyping | 1 | EA | $ - 0 | ||
| 1065 | Platelet Auto Antibodies | 1 | EA | $ - 0 | ||
| 1066 | HLA ABC Typing (Class I) | 1 | EA | $ - 0 | ||
| 1067 | HLA DR/DQ Typing (Class II) | 1 | EA | $ - 0 | ||
| 1068 | HLA for Platelet Pheresis | 1 | EA | $ - 0 | ||
| 1069 | HLA‐Antibody Intermediate Resolution, Basic | 1 | EA | $ - 0 | ||
| 1070 | RBC Genotype Bioarray (HEA) | 1 | EA | $ - 0 | ||
| 1071 | HLA ‐ ABC/DR High Resolution, DQ Low Resolution | 1 | EA | $ - 0 | ||
| 1072 | Heparin Induced Thrombocytopenia Antibody (HIT) | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 | |||||
| APHERESIS AND THERAPEUTIC SERVICES | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 1073 | HPC Apheresis | 1 | EA | $ - 0 | ||
| 1074 | Photopheresis Procedure | 1 | EA | $ - 0 | ||
| 1075 | Therapeutic Cellular Depletion ‐ WBC | 1 | EA | $ - 0 | ||
| 1076 | Therapeutic Phlebotomy (In Blood | |||||
| Center) | 1 | EA | $ - 0 | |||
| 1077 | Therapeutic phlebotomy ‐ in hospital | 1 | EA | $ - 0 | ||
| 1078 | Therapeutic phlebotomy with | |||||
| replacement fluid ‐ in hospital | 1 | EA | $ - 0 | |||
| 1079 | Red Blood Cell Exchange | 1 | EA | $ - 0 | ||
| 1080 | Therapeutic Cellular Depletion ‐ RBC | 1 | EA | $ - 0 | ||
| 1081 | Therapeutic Cellular Depletion ‐ | |||||
| Platelet | 1 | EA | $ - 0 | |||
| 1082 | Therapeutic Plasma Exchange | 74 | EA | $ - 0 | ||
| 1083 | Red Cell Prime | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 | |||||
| REFERENCE TESTING | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 1084 | Radsure Label to be Irradiated | 1 | EA | $ - 0 | ||
| 1085 | Irradiation of Unit | 38 | EA | $ - 0 | ||
| 1086 | Deglycerolization of Unit | 1 | EA | $ - 0 | ||
| 1087 | Freeze Unit | 1 | EA | $ - 0 | ||
| 1088 | Freeze & Deglycerolization Unit | 1 | EA | $ - 0 | ||
| 1089 | Pooling unit(s) | 1 | EA | $ - 0 | ||
| 1090 | Thaw Unit | 1 | EA | $ - 0 | ||
| 1091 | RBC Wash | 1 | EA | $ - 0 | ||
| 1092 | Platelet Wash | 1 | EA | $ - 0 | ||
| 1093 | RBC Crossmatch (each additional unit) | 1 | EA | $ - 0 | ||
| 1094 | Non‐crossmatch set up | 1 | EA | $ - 0 | ||
| 1095 | ABO Group | 1 | EA | $ - 0 | ||
| 1096 | RH Type | 1 | EA | $ - 0 | ||
| 1097 | Chemical Treatment | 1 | EA | $ - 0 | ||
| 1098 | Aliquot Bag | 1 | EA | $ - 0 | ||
| 1099 | Confirmatory Draw | 1 | EA | $ - 0 | ||
| 1100 | Platelet (Volume Reduction Fee) | 1 | EA | $ - 0 | ||
| 1101 | Computer Antigen Search (per Antigen) | 1 | EA | $ - 0 | ||
| 1102 | Patient Complete Phenotype, Serologic | 1 | EA | $ - 0 | ||
| 1103 | Reconstitute | 1 | EA | $ - 0 | ||
| 1104 | RBC Antibody Identification | 30 | EA | $ - 0 | ||
| 1105 | Rare Unit | 5 | EA | $ - 0 | ||
| 1106 | Antigen Typing ‐ Single | 230 | EA | $ - 0 | ||
| 1107 | RBC Selected Cell Panel | 1 | EA | $ - 0 | ||
| 1108 | RBC Cell Separation | 1 | EA | $ - 0 | ||
| 1109 | IgG Dissociation | 1 | EA | $ - 0 | ||
| 1110 | Dithiotreitol Treatment | 1 | EA | $ - 0 | ||
| 1111 | Neutralization P1 or Lewis | 1 | EA | $ - 0 | ||
| 1112 | Chloroquine treatment | 1 | EA | $ - 0 | ||
| 1113 | Acid Elution / Cell Elution | 30 | EA | $ - 0 | ||
| 1114 | Donath‐Landsteiner Test | 1 | EA | $ - 0 | ||
| 1115 | Irradiation ‐ Per Random Platelet | 1 | EA | $ - 0 | ||
| 1116 | Rare Donor Search thru American Rare Donor Program (ARDP) | 1 | EA | $ - 0 | ||
| 1117 | Splitting Service | 1 | EA | $ - 0 | ||
| 1118 | Type and Screen | 30 | EA | $ - 0 | ||
| 1119 | ABO Group & Rh Type | 75 | EA | $ - 0 | ||
| 1120 | Antibody Screen (Indirect Coombs) | 15 | EA | $ - 0 | ||
| 1121 | RBC Antibody Titer | 1 | EA | $ - 0 | ||
| 1122 | Direct Antiglobulin IgG (Direct Coombs) | 63 | EA | $ - 0 | ||
| 1123 | Direct Antiglobulin DAT C3 | 1 | EA | $ - 0 | ||
| 1124 | Fetal Screen | 1 | EA | $ - 0 | ||
| 1125 | Kleihauer ‐ Betke | 1 | EA | $ - 0 | ||
| 1126 | CMV Test | 1 | EA | $ - 0 | ||
| 1127 | Sickle Cell Screen | 6 | EA | $ - 0 | ||
| 1128 | LUI Elution | 1 | EA | $ - 0 | ||
| 1129 | RBC Antibody Panel | 158 | EA | $ - 0 | ||
| 1130 | Transfusion Reaction Work Up | 5 | EA | $ - 0 | ||
| 1131 | RBC Antigen Typing | 32 | EA | $ - 0 | ||
| 1132 | Adsorption | 32 | EA | $ - 0 | ||
| 1133 | Cold Agglutinin Titer | 1 | EA | $ - 0 | ||
| 1134 | ABO RH Cord | 1 | EA | $ - 0 | ||
| 1135 | Sterile Doc Quad Pack | 1 | EA | $ - 0 | ||
| 1136 | Enzyme Treatment | 2 | EA | $ - 0 | ||
| 1137 | Lookback | 1 | EA | $ - 0 | ||
| 1138 | Crossmatch ‐ Electronic | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 | |||||
| OTHER TESTING | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 1139 | NAT (HIV ‐ I, HBV and HCV RNA) | |||||
| DONOR ONLY | 1 | EA | $ - 0 | |||
| 1140 | Non‐Donor Infectious Disease Markers 3327 | 1 | EA | $ - 0 | ||
| 1141 | Non‐Donor Infectious Disease Markers 3486, no ABO/Rh | 1 | EA | $ - 0 | ||
| 1142 | White Blood Cell Counts by Flow Cytometry | 1 | EA | $ - 0 | ||
| 1143 | Cryoprecipitate QC | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 |
TOTAL $ - 0
| OPTION PERIOD TWO (October 1, 2020 – September 30, 2021) | |||||||
| BLOOD COMPONENTS | |||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | ||
| 2001 | Whole Blood Leukoreduced | 1 | EA | $ - 0 | |||
| 2002 | Whole Blood Leukoreduced Low | ||||||
| Volume | 1 | EA | $ - 0 | ||||
| 2003 | Whole Blood Leukoreduced Low | ||||||
| Volume Irradiated | 1 | EA | $ - 0 | ||||
| 2004 | Whole Blood Autologous | ||||||
| Leukoreduced | 1 | EA | $ - 0 | ||||
| 2005 | Red Blood Cells Leukoreduced | 2348 | EA | $ - 0 | |||
| 2006 | Red Blood Cells Leukoreduced | ||||||
| Deglycerolized | 1 | EA | $ - 0 | ||||
| 2007 | Red Blood Cells Leukoreduced Frozen | 1 | EA | $ - 0 | |||
| 2008 | Red Blood Cells Leukoreduced | ||||||
| Irradiated | 1 | EA | $ - 0 | ||||
| 2009 | Red Blood Cells Leukoreduced Low | ||||||
| Volume | 1 | EA | $ - 0 | ||||
| 2010 | Red Blood Cells Leukoreduced Washed | 1 | EA | $ - 0 | |||
| 2011 | Red Blood Cells Leukoreduced | ||||||
| Deglycerolized Irradiated | 1 | EA | $ - 0 | ||||
| 2012 | Red Blood Cells Leukoreduced | ||||||
| Irradiated Washed | 1 | EA | $ - 0 | ||||
| 2013 | Red Blood Cells Leukoreduced Processing ‐ Infant (PediCells ‐ CMV | ||||||
| Neg.,) | 1 | EA | $ - 0 | ||||
| 2014 | Red Blood Cells Autologous | ||||||
| Leukoreduced | 1 | EA | $ - 0 | ||||
| 2015 | Red Blood Cells Autologous | ||||||
| Leukoreduced Deglycerolized | 1 | EA | $ - 0 | ||||
| 2016 | Whole Blood Platelets Leukoreduced | 1 | EA | $ - 0 | |||
| 2017 | Platelet Pheresis Pedi‐D | 1 | EA | $ - 0 | |||
| 2018 | Platelet Pheresis Pedi‐W | 1 | EA | $ - 0 | |||
| 2019 | Cryoprecipitate | 1 | EA | $ - 0 | |||
| 2020 | Pooled Cryoprecipitate (5) | 1 | EA | $ - 0 | |||
| 2021 | Pooled Cryoprecipitate (10) | 15 | EA | $ - 0 | |||
| 2022 | Fresh Frozen Plasma | 423 | EA | $ - 0 | |||
| 2023 | Fresh Frozen Plasma Cryo‐removed | 1 | EA | $ - 0 | |||
| 2024 | Fresh Frozen Plasma 0‐24 | 1 | EA | $ - 0 | |||
| 2025 | Fresh Frozen Plasma ‐ Infant Dose | ||||||
| (Pediplasma Processing) | 1 | EA | $ - 0 | ||||
| 2026 | Neo‐Natal Fresh Frozen Plasma | 1 | EA | $ - 0 | |||
| 2027 | Plasma (Liquid) | 1 | EA | $ - 0 | |||
| 2028 | Plasma (Liquid) Irradiated | 1 | EA | $ - 0 | |||
| 2029 | Source Leukocyte | 1 | EA | $ - 0 | |||
| 2030 | Apheresis Platelets (SDP) | ||||||
| Leukoreduced | 343 | EA | $ - 0 | ||||
| 2031 | Apheresis Platelets (SDP) | ||||||
| Leukoreduced Irradiated | 1 | EA | $ - 0 | ||||
| 2032 | Apheresis Platelets (SDP) | ||||||
| Leukoreduced Low Volume | 1 | EA | $ - 0 | ||||
| 2033 | Apheresis Platelets (SDP)/LIW Leukoreduced Irradiated Washed | 1 | EA | $ - 0 | |||
| 2034 | Apheresis Platelets (SDP) | ||||||
| Leukoreduced Low Volume Irradiated | 1 | EA | $ - 0 | ||||
| 2035 | Apheresis Platelets (SDP) Autologous | ||||||
| Leukoreduced Irradiated | 1 | EA | $ - 0 | ||||
| 2036 | Apheresis Granulocytes | 1 | EA | $ - 0 | |||
| 2037 | Apheresis Granulocytes Irradiated | 1 | EA | $ - 0 | |||
| 2038 | Pooled Platelets Leukoreduced | 1 | EA | $ - 0 | |||
| 2039 | Pooled Platelets Leukoreduced | ||||||
| Irradiated | 1 | EA | $ - 0 | ||||
| SUBTOTAL | $ - 0 | ||||||
| CELLULAR LAB | |||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | ||
| 2040 | SC ABO Incompatible Buffy Coat Enrichment | 1 | EA | $ - 0 | |||
| 2041 | SC Plasma Depletion | 1 | EA | $ - 0 | |||
| 2042 | SC Cryopreservation (includes 1st year storage) | 1 | EA | $ - 0 | |||
| 2043 | SC Colony Forming Unit (CFU) | 1 | EA | $ - 0 | |||
| 2044 | SC Stem Cell Quality Control | 1 | EA | $ - 0 | |||
| 2045 | SC Cord Wash Process | 1 | EA | $ - 0 | |||
| 2046 | SC Cord Blood Reconstitution | 1 | EA | $ - 0 | |||
| 2047 | Stem Cell Freight | 1 | EA | $ - 0 | |||
| 2048 | SC Thawing Frozen Cell (QC Vial ea) | 1 | EA | $ - 0 | |||
| 2049 | SC CBC with automated differential | 1 | EA | $ - 0 | |||
| 2050 | SC CBC with manual differential | 1 | EA | $ - 0 | |||
| 2051 | CD34 Test | 1 | EA | $ - 0 | |||
| 2052 | SC Cellular Night and Weekend Fee | 1 | EA | $ - 0 | |||
| 2053 | SC Trypan Blue viability | 1 | EA | $ - 0 | |||
| 2054 | SC Storage greater than 1 year (storage per year) | 1 | EA | $ - 0 | |||
| 2055 | SC Sterility Check | 1 | EA | $ - 0 | |||
| 2056 | SC CD3 | 1 | EA | $ - 0 | |||
| 2057 | SC CD4 | 1 | EA | $ - 0 | |||
| 2058 | SC CD8 | 1 | EA | $ - 0 | |||
| 2059 | SC Processing Split Exceeding 4 Bags (each) | 1 | EA | $ - 0 | |||
| SUBTOTAL | $ - 0 | ||||||
| HLA AND SPECIAL HEMATOLOGY TESTING | |||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | ||
| 2060 | Platelet Crossmatch | 1 | EA | $ - 0 | |||
| 2061 | HLA/Platelet Antibody Screen (Serology/ELISA) | 1 | EA | $ - 0 | |||
| 2062 | HLA‐Antibody Intermediate Resolution, Complex | 1 | EA | $ - 0 | |||
| 2063 | Neonate Allo Thrombocytopenia Assessment | 1 | EA | $ - 0 | |||
| 2064 | Platelet Genotyping | 1 | EA | $ - 0 | |||
| 2065 | Platelet Auto Antibodies | 1 | EA | $ - 0 | |||
| 2066 | HLA ABC Typing (Class I) | 1 | EA | $ - 0 | |||
| 2067 | HLA DR/DQ Typing (Class II) | 1 | EA | $ - 0 | |||
| 2068 | HLA for Platelet Pheresis | 1 | EA | $ - 0 | |||
| 2069 | HLA‐Antibody Intermediate Resolution, Basic | 1 | EA | $ - 0 | |||
| 2070 | RBC Genotype Bioarray (HEA) | 1 | EA | $ - 0 | |||
| 2071 | HLA ‐ ABC/DR High Resolution, DQ Low Resolution | 1 | EA | $ - 0 | |||
| 2072 | Heparin Induced Thrombocytopenia Antibody (HIT) | 1 | EA | $ - 0 | |||
| SUBTOTAL | $ - 0 | ||||||
| APHERESIS AND THERAPEUTIC SERVICES | |||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | ||
| 2073 | HPC Apheresis | 1 | EA | $ - 0 | |||
| 2074 | Photopheresis Procedure | 1 | EA | $ - 0 | |||
| 2075 | Therapeutic Cellular Depletion ‐ WBC | 1 | EA | $ - 0 | |||
| 2076 | Therapeutic Phlebotomy (In Blood | ||||||
| Center) | 1 | EA | $ - 0 | ||||
| 2077 | Therapeutic phlebotomy ‐ in hospital | 1 | EA | $ - 0 | |||
| 2078 | Therapeutic phlebotomy with | ||||||
| replacement fluid ‐ in hospital | 1 | EA | $ - 0 | ||||
| 2079 | Red Blood Cell Exchange | 1 | EA | $ - 0 | |||
| 2080 | Therapeutic Cellular Depletion ‐ RBC | 1 | EA | $ - 0 | |||
| 2081 | Therapeutic Cellular Depletion ‐ | ||||||
| Platelet | 1 | EA | $ - 0 | ||||
| 2082 | Therapeutic Plasma Exchange | 74 | EA | $ - 0 | |||
| 2083 | Red Cell Prime | 1 | EA | $ - 0 | |||
| SUBTOTAL | $ - 0 | ||||||
| REFERENCE TESTING | |||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | ||
| 2084 | Radsure Label to be Irradiated | 1 | EA | $ - 0 | |||
| 2085 | Irradiation of Unit | 38 | EA | $ - 0 | |||
| 2086 | Deglycerolization of Unit | 1 | EA | $ - 0 | |||
| 2087 | Freeze Unit | 1 | EA | $ - 0 | |||
| 2088 | Freeze & Deglycerolization Unit | 1 | EA | $ - 0 | |||
| 2089 | Pooling unit(s) | 1 | EA | $ - 0 | |||
| 2090 | Thaw Unit | 1 | EA | $ - 0 | |||
| 2091 | RBC Wash | 1 | EA | $ - 0 | |||
| 2092 | Platelet Wash | 1 | EA | $ - 0 | |||
| 2093 | RBC Crossmatch (each additional unit) | 1 | EA | $ - 0 | |||
| 2094 | Non‐crossmatch set up | 1 | EA | $ - 0 | |||
| 2095 | ABO Group | 1 | EA | $ - 0 | |||
| 2096 | RH Type | 1 | EA | $ - 0 | |||
| 2097 | Chemical Treatment | 1 | EA | $ - 0 | |||
| 2098 | Aliquot Bag | 1 | EA | $ - 0 | |||
| 2099 | Confirmatory Draw | 1 | EA | $ - 0 | |||
| 2100 | Platelet (Volume Reduction Fee) | 1 | EA | $ - 0 | |||
| 2101 | Computer Antigen Search (per Antigen) | 1 | EA | $ - 0 | |||
| 2102 | Patient Complete Phenotype, Serologic | 1 | EA | $ - 0 | |||
| 2103 | Reconstitute | 1 | EA | $ - 0 | |||
| 2104 | RBC Antibody Identification | 30 | EA | $ - 0 | |||
| 2105 | Rare Unit | 5 | EA | $ - 0 | |||
| 2106 | Antigen Typing ‐ Single | 230 | EA | $ - 0 | |||
| 2107 | RBC Selected Cell Panel | 1 | EA | $ - 0 | |||
| 2108 | RBC Cell Separation | 1 | EA | $ - 0 | |||
| 2109 | IgG Dissociation | 1 | EA | $ - 0 | |||
| 2110 | Dithiotreitol Treatment | 1 | EA | $ - 0 | |||
| 2111 | Neutralization P1 or Lewis | 1 | EA | $ - 0 | |||
| 2112 | Chloroquine treatment | 1 | EA | $ - 0 | |||
| 2113 | Acid Elution / Cell Elution | 30 | EA | $ - 0 | |||
| 2114 | Donath‐Landsteiner Test | 1 | EA | $ - 0 | |||
| 2115 | Irradiation ‐ Per Random Platelet | 1 | EA | $ - 0 | |||
| 2116 | Rare Donor Search thru American Rare Donor Program (ARDP) | 1 | EA | $ - 0 | |||
| 2117 | Splitting Service | 1 | EA | $ - 0 | |||
| 2118 | Type and Screen | 30 | EA | $ - 0 | |||
| 2119 | ABO Group & Rh Type | 75 | EA | $ - 0 | |||
| 2120 | Antibody Screen (Indirect Coombs) | 15 | EA | $ - 0 | |||
| 2121 | RBC Antibody Titer | 1 | EA | $ - 0 | |||
| 2122 | Direct Antiglobulin IgG (Direct Coombs) | 63 | EA | $ - 0 | |||
| 2123 | Direct Antiglobulin DAT C3 | 1 | EA | $ - 0 | |||
| 2124 | Fetal Screen | 1 | EA | $ - 0 | |||
| 2125 | Kleihauer ‐ Betke | 1 | EA | $ - 0 | |||
| 2126 | CMV Test | 1 | EA | $ - 0 | |||
| 2127 | Sickle Cell Screen | 6 | EA | $ - 0 | |||
| 2128 | LUI Elution | 1 | EA | $ - 0 | |||
| 2129 | RBC Antibody Panel | 158 | EA | $ - 0 | |||
| 2130 | Transfusion Reaction Work Up | 5 | EA | $ - 0 | |||
| 2131 | RBC Antigen Typing | 32 | EA | $ - 0 | |||
| 2132 | Adsorption | 32 | EA | $ - 0 | |||
| 2133 | Cold Agglutinin Titer | 1 | EA | $ - 0 | |||
| 2134 | ABO RH Cord | 1 | EA | $ - 0 | |||
| 2135 | Sterile Doc Quad Pack | 1 | EA | $ - 0 | |||
| 2136 | Enzyme Treatment | 2 | EA | $ - 0 | |||
| 2137 | Lookback | 1 | EA | $ - 0 | |||
| 2138 | Crossmatch ‐ Electronic | 1 | EA | $ - 0 | |||
| SUBTOTAL | $ - 0 | ||||||
| OTHER TESTING | |||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | ||
| 2139 | NAT (HIV ‐ I, HBV and HCV RNA) | ||||||
| DONOR ONLY | 1 | EA | $ - 0 | 1 | |||
| 2140 | Non‐Donor Infectious Disease Markers 3327 | 1 | EA | $ - 0 | |||
| 2141 | Non‐Donor Infectious Disease Markers 3486, no ABO/Rh | 1 | EA | $ - 0 | |||
| 2142 | White Blood Cell Counts by Flow Cytometry | 1 | EA | $ - 0 | |||
| 2143 | Cryoprecipitate QC | 1 | EA | $ - 0 | |||
| SUBTOTAL | $ - 0 |
TOTAL $ - 0
| OPTION PERIOD THREE (October 1, 2021 – September 30, 2022) | ||||||
| BLOOD COMPONENTS | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 3001 | Whole Blood Leukoreduced | 1 | EA | $ - 0 | ||
| 3002 | Whole Blood Leukoreduced Low | |||||
| Volume | 1 | EA | $ - 0 | |||
| 3003 | Whole Blood Leukoreduced Low | |||||
| Volume Irradiated | 1 | EA | $ - 0 | |||
| 3004 | Whole Blood Autologous | |||||
| Leukoreduced | 1 | EA | $ - 0 | |||
| 3005 | Red Blood Cells Leukoreduced | 2348 | EA | $ - 0 | ||
| 3006 | Red Blood Cells Leukoreduced | |||||
| Deglycerolized | 1 | EA | $ - 0 | |||
| 3007 | Red Blood Cells Leukoreduced Frozen | 1 | EA | $ - 0 | ||
| 3008 | Red Blood Cells Leukoreduced | |||||
| Irradiated | 1 | EA | $ - 0 | |||
| 3009 | Red Blood Cells Leukoreduced Low | |||||
| Volume | 1 | EA | $ - 0 | |||
| 3010 | Red Blood Cells Leukoreduced Washed | 1 | EA | $ - 0 | ||
| 3011 | Red Blood Cells Leukoreduced | |||||
| Deglycerolized Irradiated | 1 | EA | $ - 0 | |||
| 3012 | Red Blood Cells Leukoreduced | |||||
| Irradiated Washed | 1 | EA | $ - 0 | |||
| 3013 | Red Blood Cells Leukoreduced Processing ‐ Infant (PediCells ‐ CMV | |||||
| Neg.,) | 1 | EA | $ - 0 | |||
| 3014 | Red Blood Cells Autologous | |||||
| Leukoreduced | 1 | EA | $ - 0 | |||
| 3015 | Red Blood Cells Autologous | |||||
| Leukoreduced Deglycerolized | 1 | EA | $ - 0 | |||
| 3016 | Whole Blood Platelets Leukoreduced | 1 | EA | $ - 0 | ||
| 3017 | Platelet Pheresis Pedi‐D | 1 | EA | $ - 0 | ||
| 3018 | Platelet Pheresis Pedi‐W | 1 | EA | $ - 0 | ||
| 3019 | Cryoprecipitate | 1 | EA | $ - 0 | ||
| 3020 | Pooled Cryoprecipitate (5) | 1 | EA | $ - 0 | ||
| 3021 | Pooled Cryoprecipitate (10) | 15 | EA | $ - 0 | ||
| 3022 | Fresh Frozen Plasma | 423 | EA | $ - 0 | ||
| 3023 | Fresh Frozen Plasma Cryo‐removed | 1 | EA | $ - 0 | ||
| 3024 | Fresh Frozen Plasma 0‐24 | 1 | EA | $ - 0 | ||
| 3025 | Fresh Frozen Plasma ‐ Infant Dose | |||||
| (Pediplasma Processing) | 1 | EA | $ - 0 | |||
| 3026 | Neo‐Natal Fresh Frozen Plasma | 1 | EA | $ - 0 | ||
| 3027 | Plasma (Liquid) | 1 | EA | $ - 0 | ||
| 3028 | Plasma (Liquid) Irradiated | 1 | EA | $ - 0 | ||
| 3029 | Source Leukocyte | 1 | EA | $ - 0 | ||
| 3030 | Apheresis Platelets (SDP) | |||||
| Leukoreduced | 343 | EA | $ - 0 | |||
| 3031 | Apheresis Platelets (SDP) | |||||
| Leukoreduced Irradiated | 1 | EA | $ - 0 | |||
| 3032 | Apheresis Platelets (SDP) | |||||
| Leukoreduced Low Volume | 1 | EA | $ - 0 | |||
| 3033 | Apheresis Platelets (SDP)/LIW Leukoreduced Irradiated Washed | 1 | EA | $ - 0 | ||
| 3034 | Apheresis Platelets (SDP) | |||||
| Leukoreduced Low Volume Irradiated | 1 | EA | $ - 0 | |||
| 3035 | Apheresis Platelets (SDP) Autologous | |||||
| Leukoreduced Irradiated | 1 | EA | $ - 0 | |||
| 3036 | Apheresis Granulocytes | 1 | EA | $ - 0 | ||
| 3037 | Apheresis Granulocytes Irradiated | 1 | EA | $ - 0 | ||
| 3038 | Pooled Platelets Leukoreduced | 1 | EA | $ - 0 | ||
| 3039 | Pooled Platelets Leukoreduced | |||||
| Irradiated | 1 | EA | $ - 0 | |||
| SUBTOTAL | $ - 0 | |||||
| CELLULAR LAB | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 3040 | SC ABO Incompatible Buffy Coat Enrichment | 1 | EA | $ - 0 | ||
| 3041 | SC Plasma Depletion | 1 | EA | $ - 0 | ||
| 3042 | SC Cryopreservation (includes 1st year storage) | 1 | EA | $ - 0 | ||
| 3043 | SC Colony Forming Unit (CFU) | 1 | EA | $ - 0 | ||
| 3044 | SC Stem Cell Quality Control | 1 | EA | $ - 0 | ||
| 3045 | SC Cord Wash Process | 1 | EA | $ - 0 | ||
| 3046 | SC Cord Blood Reconstitution | 1 | EA | $ - 0 | ||
| 3047 | Stem Cell Freight | 1 | EA | $ - 0 | ||
| 3048 | SC Thawing Frozen Cell (QC Vial ea) | 1 | EA | $ - 0 | ||
| 3049 | SC CBC with automated differential | 1 | EA | $ - 0 | ||
| 3050 | SC CBC with manual differential | 1 | EA | $ - 0 | ||
| 3051 | CD34 Test | 1 | EA | $ - 0 | ||
| 3052 | SC Cellular Night and Weekend Fee | 1 | EA | $ - 0 | ||
| 3053 | SC Trypan Blue viability | 1 | EA | $ - 0 | ||
| 3054 | SC Storage greater than 1 year (storage per year) | 1 | EA | $ - 0 | ||
| 3055 | SC Sterility Check | 1 | EA | $ - 0 | ||
| 3056 | SC CD3 | 1 | EA | $ - 0 | ||
| 3057 | SC CD4 | 1 | EA | $ - 0 | ||
| 3058 | SC CD8 | 1 | EA | $ - 0 | ||
| 3059 | SC Processing Split Exceeding 4 Bags (each) | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 | |||||
| HLA AND SPECIAL HEMATOLOGY TESTING | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 3060 | Platelet Crossmatch | 1 | EA | $ - 0 | ||
| 3061 | HLA/Platelet Antibody Screen (Serology/ELISA) | 1 | EA | $ - 0 | ||
| 3062 | HLA‐Antibody Intermediate Resolution, Complex | 1 | EA | $ - 0 | ||
| 3063 | Neonate Allo Thrombocytopenia Assessment | 1 | EA | $ - 0 | ||
| 3064 | Platelet Genotyping | 1 | EA | $ - 0 | ||
| 3065 | Platelet Auto Antibodies | 1 | EA | $ - 0 | ||
| 3066 | HLA ABC Typing (Class I) | 1 | EA | $ - 0 | ||
| 3067 | HLA DR/DQ Typing (Class II) | 1 | EA | $ - 0 | ||
| 3068 | HLA for Platelet Pheresis | 1 | EA | $ - 0 | ||
| 3069 | HLA‐Antibody Intermediate Resolution, Basic | 1 | EA | $ - 0 | ||
| 3070 | RBC Genotype Bioarray (HEA) | 1 | EA | $ - 0 | ||
| 3071 | HLA ‐ ABC/DR High Resolution, DQ Low Resolution | 1 | EA | $ - 0 | ||
| 3072 | Heparin Induced Thrombocytopenia Antibody (HIT) | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 | |||||
| APHERESIS AND THERAPEUTIC SERVICES | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 3073 | HPC Apheresis | 1 | EA | $ - 0 | ||
| 3074 | Photopheresis Procedure | 1 | EA | $ - 0 | ||
| 3075 | Therapeutic Cellular Depletion ‐ WBC | 1 | EA | $ - 0 | ||
| 3076 | Therapeutic Phlebotomy (In Blood | |||||
| Center) | 1 | EA | $ - 0 | |||
| 3077 | Therapeutic phlebotomy ‐ in hospital | 1 | EA | $ - 0 | ||
| 3078 | Therapeutic phlebotomy with | |||||
| replacement fluid ‐ in hospital | 1 | EA | $ - 0 | |||
| 3079 | Red Blood Cell Exchange | 1 | EA | $ - 0 | ||
| 3080 | Therapeutic Cellular Depletion ‐ RBC | 1 | EA | $ - 0 | ||
| 3081 | Therapeutic Cellular Depletion ‐ | |||||
| Platelet | 1 | EA | $ - 0 | |||
| 3082 | Therapeutic Plasma Exchange | 74 | EA | $ - 0 | ||
| 3083 | Red Cell Prime | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 | |||||
| REFERENCE TESTING | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 3084 | Radsure Label to be Irradiated | 1 | EA | $ - 0 | ||
| 3085 | Irradiation of Unit | 38 | EA | $ - 0 | ||
| 3086 | Deglycerolization of Unit | 1 | EA | $ - 0 | ||
| 3087 | Freeze Unit | 1 | EA | $ - 0 | ||
| 3088 | Freeze & Deglycerolization Unit | 1 | EA | $ - 0 | ||
| 3089 | Pooling unit(s) | 1 | EA | $ - 0 | ||
| 3090 | Thaw Unit | 1 | EA | $ - 0 | ||
| 3091 | RBC Wash | 1 | EA | $ - 0 | ||
| 3092 | Platelet Wash | 1 | EA | $ - 0 | ||
| 3093 | RBC Crossmatch (each additional unit) | 1 | EA | $ - 0 | ||
| 3094 | Non‐crossmatch set up | 1 | EA | $ - 0 | ||
| 3095 | ABO Group | 1 | EA | $ - 0 | ||
| 3096 | RH Type | 1 | EA | $ - 0 | ||
| 3097 | Chemical Treatment | 1 | EA | $ - 0 | ||
| 3098 | Aliquot Bag | 1 | EA | $ - 0 | ||
| 3099 | Confirmatory Draw | 1 | EA | $ - 0 | ||
| 3100 | Platelet (Volume Reduction Fee) | 1 | EA | $ - 0 | ||
| 3101 | Computer Antigen Search (per Antigen) | 1 | EA | $ - 0 | ||
| 3102 | Patient Complete Phenotype, Serologic | 1 | EA | $ - 0 | ||
| 3103 | Reconstitute | 1 | EA | $ - 0 | ||
| 3104 | RBC Antibody Identification | 30 | EA | $ - 0 | ||
| 3105 | Rare Unit | 5 | EA | $ - 0 | ||
| 3106 | Antigen Typing ‐ Single | 230 | EA | $ - 0 | ||
| 3107 | RBC Selected Cell Panel | 1 | EA | $ - 0 | ||
| 3108 | RBC Cell Separation | 1 | EA | $ - 0 | ||
| 3109 | IgG Dissociation | 1 | EA | $ - 0 | ||
| 3110 | Dithiotreitol Treatment | 1 | EA | $ - 0 | ||
| 3111 | Neutralization P1 or Lewis | 1 | EA | $ - 0 | ||
| 3112 | Chloroquine treatment | 1 | EA | $ - 0 | ||
| 3113 | Acid Elution / Cell Elution | 30 | EA | $ - 0 | ||
| 3114 | Donath‐Landsteiner Test | 1 | EA | $ - 0 | ||
| 3115 | Irradiation ‐ Per Random Platelet | 1 | EA | $ - 0 | ||
| 3116 | Rare Donor Search thru American Rare Donor Program (ARDP) | 1 | EA | $ - 0 | ||
| 3117 | Splitting Service | 1 | EA | $ - 0 | ||
| 3118 | Type and Screen | 30 | EA | $ - 0 | ||
| 3119 | ABO Group & Rh Type | 75 | EA | $ - 0 | ||
| 3120 | Antibody Screen (Indirect Coombs) | 15 | EA | $ - 0 | ||
| 3121 | RBC Antibody Titer | 1 | EA | $ - 0 | ||
| 3122 | Direct Antiglobulin IgG (Direct Coombs) | 63 | EA | $ - 0 | ||
| 3123 | Direct Antiglobulin DAT C3 | 1 | EA | $ - 0 | ||
| 3124 | Fetal Screen | 1 | EA | $ - 0 | ||
| 3125 | Kleihauer ‐ Betke | 1 | EA | $ - 0 | ||
| 3126 | CMV Test | 1 | EA | $ - 0 | ||
| 3127 | Sickle Cell Screen | 6 | EA | $ - 0 | ||
| 3128 | LUI Elution | 1 | EA | $ - 0 | ||
| 3129 | RBC Antibody Panel | 158 | EA | $ - 0 | ||
| 3130 | Transfusion Reaction Work Up | 5 | EA | $ - 0 | ||
| 3131 | RBC Antigen Typing | 32 | EA | $ - 0 | ||
| 3132 | Adsorption | 32 | EA | $ - 0 | ||
| 3133 | Cold Agglutinin Titer | 1 | EA | $ - 0 | ||
| 3134 | ABO RH Cord | 1 | EA | $ - 0 | ||
| 3135 | Sterile Doc Quad Pack | 1 | EA | $ - 0 | ||
| 3136 | Enzyme Treatment | 2 | EA | $ - 0 | ||
| 3137 | Lookback | 1 | EA | $ - 0 | ||
| 3138 | Crossmatch ‐ Electronic | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 | |||||
| OTHER TESTING | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 3139 | NAT (HIV ‐ I, HBV and HCV RNA) | |||||
| DONOR ONLY | 1 | EA | $ - 0 | |||
| 3140 | Non‐Donor Infectious Disease Markers 3327 | 1 | EA | $ - 0 | ||
| 3141 | Non‐Donor Infectious Disease Markers 3486, no ABO/Rh | 1 | EA | $ - 0 | ||
| 3142 | White Blood Cell Counts by Flow Cytometry | 1 | EA | $ - 0 | ||
| 3143 | Cryoprecipitate QC | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 |
TOTAL $ - 0
| OPTION PERIOD FOUR (October 1, 2022 – September 30, 2023) | ||||||
| BLOOD COMPONENTS | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 4001 | Whole Blood Leukoreduced | 1 | EA | $ - 0 | ||
| 4002 | Whole Blood Leukoreduced Low | |||||
| Volume | 1 | EA | $ - 0 | |||
| 4003 | Whole Blood Leukoreduced Low | |||||
| Volume Irradiated | 1 | EA | $ - 0 | |||
| 4004 | Whole Blood Autologous | |||||
| Leukoreduced | 1 | EA | $ - 0 | |||
| 4005 | Red Blood Cells Leukoreduced | 2348 | EA | $ - 0 | ||
| 4006 | Red Blood Cells Leukoreduced | |||||
| Deglycerolized | 1 | EA | $ - 0 | |||
| 4007 | Red Blood Cells Leukoreduced Frozen | 1 | EA | $ - 0 | ||
| 4008 | Red Blood Cells Leukoreduced | |||||
| Irradiated | 1 | EA | $ - 0 | |||
| 4009 | Red Blood Cells Leukoreduced Low | |||||
| Volume | 1 | EA | $ - 0 | |||
| 4010 | Red Blood Cells Leukoreduced Washed | 1 | EA | $ - 0 | ||
| 4011 | Red Blood Cells Leukoreduced | |||||
| Deglycerolized Irradiated | 1 | EA | $ - 0 | |||
| 4012 | Red Blood Cells Leukoreduced | |||||
| Irradiated Washed | 1 | EA | $ - 0 | |||
| 4013 | Red Blood Cells Leukoreduced Processing ‐ Infant (PediCells ‐ CMV | |||||
| Neg.,) | 1 | EA | $ - 0 | |||
| 4014 | Red Blood Cells Autologous | |||||
| Leukoreduced | 1 | EA | $ - 0 | |||
| 4015 | Red Blood Cells Autologous | |||||
| Leukoreduced Deglycerolized | 1 | EA | $ - 0 | |||
| 4016 | Whole Blood Platelets Leukoreduced | 1 | EA | $ - 0 | ||
| 4017 | Platelet Pheresis Pedi‐D | 1 | EA | $ - 0 | ||
| 4018 | Platelet Pheresis Pedi‐W | 1 | EA | $ - 0 | ||
| 4019 | Cryoprecipitate | 1 | EA | $ - 0 | ||
| 4020 | Pooled Cryoprecipitate (5) | 1 | EA | $ - 0 | ||
| 4021 | Pooled Cryoprecipitate (10) | 15 | EA | $ - 0 | ||
| 4022 | Fresh Frozen Plasma | 423 | EA | $ - 0 | ||
| 4023 | Fresh Frozen Plasma Cryo‐removed | 1 | EA | $ - 0 | ||
| 4024 | Fresh Frozen Plasma 0‐24 | 1 | EA | $ - 0 | ||
| 4025 | Fresh Frozen Plasma ‐ Infant Dose | |||||
| (Pediplasma Processing) | 1 | EA | $ - 0 | |||
| 4026 | Neo‐Natal Fresh Frozen Plasma | 1 | EA | $ - 0 | ||
| 4027 | Plasma (Liquid) | 1 | EA | $ - 0 | ||
| 4028 | Plasma (Liquid) Irradiated | 1 | EA | $ - 0 | ||
| 4029 | Source Leukocyte | 1 | EA | $ - 0 | ||
| 4030 | Apheresis Platelets (SDP) | |||||
| Leukoreduced | 343 | EA | $ - 0 | |||
| 4031 | Apheresis Platelets (SDP) | |||||
| Leukoreduced Irradiated | 1 | EA | $ - 0 | |||
| 4032 | Apheresis Platelets (SDP) | |||||
| Leukoreduced Low Volume | 1 | EA | $ - 0 | |||
| 4033 | Apheresis Platelets (SDP)/LIW Leukoreduced Irradiated Washed | 1 | EA | $ - 0 | ||
| 4034 | Apheresis Platelets (SDP) | |||||
| Leukoreduced Low Volume Irradiated | 1 | EA | $ - 0 | |||
| 4035 | Apheresis Platelets (SDP) Autologous | |||||
| Leukoreduced Irradiated | 1 | EA | $ - 0 | |||
| 4036 | Apheresis Granulocytes | 1 | EA | $ - 0 | ||
| 4037 | Apheresis Granulocytes Irradiated | 1 | EA | $ - 0 | ||
| 4038 | Pooled Platelets Leukoreduced | 1 | EA | $ - 0 | ||
| 4039 | Pooled Platelets Leukoreduced | |||||
| Irradiated | 1 | EA | $ - 0 | |||
| SUBTOTAL | $ - 0 | |||||
| CELLULAR LAB | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 4040 | SC ABO Incompatible Buffy Coat Enrichment | 1 | EA | $ - 0 | ||
| 4041 | SC Plasma Depletion | 1 | EA | $ - 0 | ||
| 4042 | SC Cryopreservation (includes 1st year storage) | 1 | EA | $ - 0 | ||
| 4043 | SC Colony Forming Unit (CFU) | 1 | EA | $ - 0 | ||
| 4044 | SC Stem Cell Quality Control | 1 | EA | $ - 0 | ||
| 4045 | SC Cord Wash Process | 1 | EA | $ - 0 | ||
| 4046 | SC Cord Blood Reconstitution | 1 | EA | $ - 0 | ||
| 4047 | Stem Cell Freight | 1 | EA | $ - 0 | ||
| 4048 | SC Thawing Frozen Cell (QC Vial ea) | 1 | EA | $ - 0 | ||
| 4049 | SC CBC with automated differential | 1 | EA | $ - 0 | ||
| 4050 | SC CBC with manual differential | 1 | EA | $ - 0 | ||
| 4051 | CD34 Test | 1 | EA | $ - 0 | ||
| 4052 | SC Cellular Night and Weekend Fee | 1 | EA | $ - 0 | ||
| 4053 | SC Trypan Blue viability | 1 | EA | $ - 0 | ||
| 4054 | SC Storage greater than 1 year (storage per year) | 1 | EA | $ - 0 | ||
| 4055 | SC Sterility Check | 1 | EA | $ - 0 | ||
| 4056 | SC CD3 | 1 | EA | $ - 0 | ||
| 4057 | SC CD4 | 1 | EA | $ - 0 | ||
| 4058 | SC CD8 | 1 | EA | $ - 0 | ||
| 4059 | SC Processing Split Exceeding 4 Bags (each) | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 | |||||
| HLA AND SPECIAL HEMATOLOGY TESTING | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 4060 | Platelet Crossmatch | 1 | EA | $ - 0 | ||
| 4061 | HLA/Platelet Antibody Screen (Serology/ELISA) | 1 | EA | $ - 0 | ||
| 4062 | HLA‐Antibody Intermediate Resolution, Complex | 1 | EA | $ - 0 | ||
| 4063 | Neonate Allo Thrombocytopenia Assessment | 1 | EA | $ - 0 | ||
| 4064 | Platelet Genotyping | 1 | EA | $ - 0 | ||
| 4065 | Platelet Auto Antibodies | 1 | EA | $ - 0 | ||
| 4066 | HLA ABC Typing (Class I) | 1 | EA | $ - 0 | ||
| 4067 | HLA DR/DQ Typing (Class II) | 1 | EA | $ - 0 | ||
| 4068 | HLA for Platelet Pheresis | 1 | EA | $ - 0 | ||
| 4069 | HLA‐Antibody Intermediate Resolution, Basic | 1 | EA | $ - 0 | ||
| 4070 | RBC Genotype Bioarray (HEA) | 1 | EA | $ - 0 | ||
| 4071 | HLA ‐ ABC/DR High Resolution, DQ Low Resolution | 1 | EA | $ - 0 | ||
| 4072 | Heparin Induced Thrombocytopenia Antibody (HIT) | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 | |||||
| APHERESIS AND THERAPEUTIC SERVICES | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 4073 | HPC Apheresis | 1 | EA | $ - 0 | ||
| 4074 | Photopheresis Procedure | 1 | EA | $ - 0 | ||
| 4075 | Therapeutic Cellular Depletion ‐ WBC | 1 | EA | $ - 0 | ||
| 4076 | Therapeutic Phlebotomy (In Blood | |||||
| Center) | 1 | EA | $ - 0 | |||
| 4077 | Therapeutic phlebotomy ‐ in hospital | 1 | EA | $ - 0 | ||
| 4078 | Therapeutic phlebotomy with | |||||
| replacement fluid ‐ in hospital | 1 | EA | $ - 0 | |||
| 4079 | Red Blood Cell Exchange | 1 | EA | $ - 0 | ||
| 4080 | Therapeutic Cellular Depletion ‐ RBC | 1 | EA | $ - 0 | ||
| 4081 | Therapeutic Cellular Depletion ‐ | |||||
| Platelet | 1 | EA | $ - 0 | |||
| 4082 | Therapeutic Plasma Exchange | 74 | EA | $ - 0 | ||
| 4083 | Red Cell Prime | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 | |||||
| REFERENCE TESTING | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 4084 | Radsure Label to be Irradiated | 1 | EA | $ - 0 | ||
| 4085 | Irradiation of Unit | 38 | EA | $ - 0 | ||
| 4086 | Deglycerolization of Unit | 1 | EA | $ - 0 | ||
| 4087 | Freeze Unit | 1 | EA | $ - 0 | ||
| 4088 | Freeze & Deglycerolization Unit | 1 | EA | $ - 0 | ||
| 4089 | Pooling unit(s) | 1 | EA | $ - 0 | ||
| 4090 | Thaw Unit | 1 | EA | $ - 0 | ||
| 4091 | RBC Wash | 1 | EA | $ - 0 | ||
| 4092 | Platelet Wash | 1 | EA | $ - 0 | ||
| 4093 | RBC Crossmatch (each additional unit) | 1 | EA | $ - 0 | ||
| 4094 | Non‐crossmatch set up | 1 | EA | $ - 0 | ||
| 4095 | ABO Group | 1 | EA | $ - 0 | ||
| 4096 | RH Type | 1 | EA | $ - 0 | ||
| 4097 | Chemical Treatment | 1 | EA | $ - 0 | ||
| 4098 | Aliquot Bag | 1 | EA | $ - 0 | ||
| 4099 | Confirmatory Draw | 1 | EA | $ - 0 | ||
| 4100 | Platelet (Volume Reduction Fee) | 1 | EA | $ - 0 | ||
| 4101 | Computer Antigen Search (per Antigen) | 1 | EA | $ - 0 | ||
| 4102 | Patient Complete Phenotype, Serologic | 1 | EA | $ - 0 | ||
| 4103 | Reconstitute | 1 | EA | $ - 0 | ||
| 4104 | RBC Antibody Identification | 30 | EA | $ - 0 | ||
| 4105 | Rare Unit | 5 | EA | $ - 0 | ||
| 4106 | Antigen Typing ‐ Single | 230 | EA | $ - 0 | ||
| 4107 | RBC Selected Cell Panel | 1 | EA | $ - 0 | ||
| 4108 | RBC Cell Separation | 1 | EA | $ - 0 | ||
| 4109 | IgG Dissociation | 1 | EA | $ - 0 | ||
| 4110 | Dithiotreitol Treatment | 1 | EA | $ - 0 | ||
| 4111 | Neutralization P1 or Lewis | 1 | EA | $ - 0 | ||
| 4112 | Chloroquine treatment | 1 | EA | $ - 0 | ||
| 4113 | Acid Elution / Cell Elution | 30 | EA | $ - 0 | ||
| 4114 | Donath‐Landsteiner Test | 1 | EA | $ - 0 | ||
| 4115 | Irradiation ‐ Per Random Platelet | 1 | EA | $ - 0 | ||
| 4116 | Rare Donor Search thru American Rare Donor Program (ARDP) | 1 | EA | $ - 0 | ||
| 4117 | Splitting Service | 1 | EA | $ - 0 | ||
| 4118 | Type and Screen | 30 | EA | $ - 0 | ||
| 4119 | ABO Group & Rh Type | 75 | EA | $ - 0 | ||
| 4120 | Antibody Screen (Indirect Coombs) | 15 | EA | $ - 0 | ||
| 4121 | RBC Antibody Titer | 1 | EA | $ - 0 | ||
| 4122 | Direct Antiglobulin IgG (Direct Coombs) | 63 | EA | $ - 0 | ||
| 4123 | Direct Antiglobulin DAT C3 | 1 | EA | $ - 0 | ||
| 4124 | Fetal Screen | 1 | EA | $ - 0 | ||
| 4125 | Kleihauer ‐ Betke | 1 | EA | $ - 0 | ||
| 4126 | CMV Test | 1 | EA | $ - 0 | ||
| 4127 | Sickle Cell Screen | 6 | EA | $ - 0 | ||
| 4128 | LUI Elution | 1 | EA | $ - 0 | ||
| 4129 | RBC Antibody Panel | 158 | EA | $ - 0 | ||
| 4130 | Transfusion Reaction Work Up | 5 | EA | $ - 0 | ||
| 4131 | RBC Antigen Typing | 32 | EA | $ - 0 | ||
| 4132 | Adsorption | 32 | EA | $ - 0 | ||
| 4133 | Cold Agglutinin Titer | 1 | EA | $ - 0 | ||
| 4134 | ABO RH Cord | 1 | EA | $ - 0 | ||
| 4135 | Sterile Doc Quad Pack | 1 | EA | $ - 0 | ||
| 4136 | Enzyme Treatment | 2 | EA | $ - 0 | ||
| 4137 | Lookback | 1 | EA | $ - 0 | ||
| 4138 | Crossmatch ‐ Electronic | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 | |||||
| OTHER TESTING | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 4139 | NAT (HIV ‐ I, HBV and HCV RNA) | |||||
| DONOR ONLY | 1 | EA | $ - 0 | |||
| 4140 | Non‐Donor Infectious Disease Markers 3327 | 1 | EA | $ - 0 | ||
| 4141 | Non‐Donor Infectious Disease Markers 3486, no ABO/Rh | 1 | EA | $ - 0 | ||
| 4142 | White Blood Cell Counts by Flow Cytometry | 1 | EA | $ - 0 | ||
| 4143 | Cryoprecipitate QC | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 |
TOTAL $ - 0
| OPTION PERIOD FIVE (October 1, 2023 – December 31, 2023) | ||||||
| BLOOD COMPONENTS | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 5001 | Whole Blood Leukoreduced | 1 | EA | $ - 0 | ||
| 5002 | Whole Blood Leukoreduced Low | |||||
| Volume | 1 | EA | $ - 0 | |||
| 5003 | Whole Blood Leukoreduced Low | |||||
| Volume Irradiated | 1 | EA | $ - 0 | |||
| 5004 | Whole Blood Autologous | |||||
| Leukoreduced | 1 | EA | $ - 0 | |||
| 5005 | Red Blood Cells Leukoreduced | 2348 | EA | $ - 0 | ||
| 5006 | Red Blood Cells Leukoreduced | |||||
| Deglycerolized | 1 | EA | $ - 0 | |||
| 5007 | Red Blood Cells Leukoreduced Frozen | 1 | EA | $ - 0 | ||
| 5008 | Red Blood Cells Leukoreduced | |||||
| Irradiated | 1 | EA | $ - 0 | |||
| 5009 | Red Blood Cells Leukoreduced Low | |||||
| Volume | 1 | EA | $ - 0 | |||
| 5010 | Red Blood Cells Leukoreduced Washed | 1 | EA | $ - 0 | ||
| 5011 | Red Blood Cells Leukoreduced | |||||
| Deglycerolized Irradiated | 1 | EA | $ - 0 | |||
| 5012 | Red Blood Cells Leukoreduced | |||||
| Irradiated Washed | 1 | EA | $ - 0 | |||
| 5013 | Red Blood Cells Leukoreduced Processing ‐ Infant (PediCells ‐ CMV | |||||
| Neg.,) | 1 | EA | $ - 0 | |||
| 5014 | Red Blood Cells Autologous | |||||
| Leukoreduced | 1 | EA | $ - 0 | |||
| 5015 | Red Blood Cells Autologous | |||||
| Leukoreduced Deglycerolized | 1 | EA | $ - 0 | |||
| 5016 | Whole Blood Platelets Leukoreduced | 1 | EA | $ - 0 | ||
| 5017 | Platelet Pheresis Pedi‐D | 1 | EA | $ - 0 | ||
| 5018 | Platelet Pheresis Pedi‐W | 1 | EA | $ - 0 | ||
| 5019 | Cryoprecipitate | 1 | EA | $ - 0 | ||
| 5020 | Pooled Cryoprecipitate (5) | 1 | EA | $ - 0 | ||
| 5021 | Pooled Cryoprecipitate (10) | 15 | EA | $ - 0 | ||
| 5022 | Fresh Frozen Plasma | 423 | EA | $ - 0 | ||
| 5023 | Fresh Frozen Plasma Cryo‐removed | 1 | EA | $ - 0 | ||
| 5024 | Fresh Frozen Plasma 0‐24 | 1 | EA | $ - 0 | ||
| 5025 | Fresh Frozen Plasma ‐ Infant Dose | |||||
| (Pediplasma Processing) | 1 | EA | $ - 0 | |||
| 5026 | Neo‐Natal Fresh Frozen Plasma | 1 | EA | $ - 0 | ||
| 5027 | Plasma (Liquid) | 1 | EA | $ - 0 | ||
| 5028 | Plasma (Liquid) Irradiated | 1 | EA | $ - 0 | ||
| 5029 | Source Leukocyte | 1 | EA | $ - 0 | ||
| 5030 | Apheresis Platelets (SDP) | |||||
| Leukoreduced | 343 | EA | $ - 0 | |||
| 5031 | Apheresis Platelets (SDP) | |||||
| Leukoreduced Irradiated | 1 | EA | $ - 0 | |||
| 5032 | Apheresis Platelets (SDP) | |||||
| Leukoreduced Low Volume | 1 | EA | $ - 0 | |||
| 5033 | Apheresis Platelets (SDP)/LIW Leukoreduced Irradiated Washed | 1 | EA | $ - 0 | ||
| 5034 | Apheresis Platelets (SDP) | |||||
| Leukoreduced Low Volume Irradiated | 1 | EA | $ - 0 | |||
| 5035 | Apheresis Platelets (SDP) Autologous | |||||
| Leukoreduced Irradiated | 1 | EA | $ - 0 | |||
| 5036 | Apheresis Granulocytes | 1 | EA | $ - 0 | ||
| 5037 | Apheresis Granulocytes Irradiated | 1 | EA | $ - 0 | ||
| 5038 | Pooled Platelets Leukoreduced | 1 | EA | $ - 0 | ||
| 5039 | Pooled Platelets Leukoreduced | |||||
| Irradiated | 1 | EA | $ - 0 | |||
| SUBTOTAL | $ - 0 | |||||
| CELLULAR LAB | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 5040 | SC ABO Incompatible Buffy Coat Enrichment | 1 | EA | $ - 0 | ||
| 5041 | SC Plasma Depletion | 1 | EA | $ - 0 | ||
| 5042 | SC Cryopreservation (includes 1st year storage) | 1 | EA | $ - 0 | ||
| 5043 | SC Colony Forming Unit (CFU) | 1 | EA | $ - 0 | ||
| 5044 | SC Stem Cell Quality Control | 1 | EA | $ - 0 | ||
| 5045 | SC Cord Wash Process | 1 | EA | $ - 0 | ||
| 5046 | SC Cord Blood Reconstitution | 1 | EA | $ - 0 | ||
| 5047 | Stem Cell Freight | 1 | EA | $ - 0 | ||
| 5048 | SC Thawing Frozen Cell (QC Vial ea) | 1 | EA | $ - 0 | ||
| 5049 | SC CBC with automated differential | 1 | EA | $ - 0 | ||
| 5050 | SC CBC with manual differential | 1 | EA | $ - 0 | ||
| 5051 | CD34 Test | 1 | EA | $ - 0 | ||
| 5052 | SC Cellular Night and Weekend Fee | 1 | EA | $ - 0 | ||
| 5053 | SC Trypan Blue viability | 1 | EA | $ - 0 | ||
| 5054 | SC Storage greater than 1 year (storage per year) | 1 | EA | $ - 0 | ||
| 5055 | SC Sterility Check | 1 | EA | $ - 0 | ||
| 5056 | SC CD3 | 1 | EA | $ - 0 | ||
| 5057 | SC CD4 | 1 | EA | $ - 0 | ||
| 5058 | SC CD8 | 1 | EA | $ - 0 | ||
| 5059 | SC Processing Split Exceeding 4 Bags (each) | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 | |||||
| HLA AND SPECIAL HEMATOLOGY TESTING | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 5060 | Platelet Crossmatch | 1 | EA | $ - 0 | ||
| 5061 | HLA/Platelet Antibody Screen (Serology/ELISA) | 1 | EA | $ - 0 | ||
| 5062 | HLA‐Antibody Intermediate Resolution, Complex | 1 | EA | $ - 0 | ||
| 5063 | Neonate Allo Thrombocytopenia Assessment | 1 | EA | $ - 0 | ||
| 5064 | Platelet Genotyping | 1 | EA | $ - 0 | ||
| 5065 | Platelet Auto Antibodies | 1 | EA | $ - 0 | ||
| 5066 | HLA ABC Typing (Class I) | 1 | EA | $ - 0 | ||
| 5067 | HLA DR/DQ Typing (Class II) | 1 | EA | $ - 0 | ||
| 5068 | HLA for Platelet Pheresis | 1 | EA | $ - 0 | ||
| 5069 | HLA‐Antibody Intermediate Resolution, Basic | 1 | EA | $ - 0 | ||
| 5070 | RBC Genotype Bioarray (HEA) | 1 | EA | $ - 0 | ||
| 5071 | HLA ‐ ABC/DR High Resolution, DQ Low Resolution | 1 | EA | $ - 0 | ||
| 5072 | Heparin Induced Thrombocytopenia Antibody (HIT) | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 | |||||
| APHERESIS AND THERAPEUTIC SERVICES | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 5073 | HPC Apheresis | 1 | EA | $ - 0 | ||
| 5074 | Photopheresis Procedure | 1 | EA | $ - 0 | ||
| 5075 | Therapeutic Cellular Depletion ‐ WBC | 1 | EA | $ - 0 | ||
| 5076 | Therapeutic Phlebotomy (In Blood | |||||
| Center) | 1 | EA | $ - 0 | |||
| 5077 | Therapeutic phlebotomy ‐ in hospital | 1 | EA | $ - 0 | ||
| 5078 | Therapeutic phlebotomy with | |||||
| replacement fluid ‐ in hospital | 1 | EA | $ - 0 | |||
| 5079 | Red Blood Cell Exchange | 1 | EA | $ - 0 | ||
| 5080 | Therapeutic Cellular Depletion ‐ RBC | 1 | EA | $ - 0 | ||
| 5081 | Therapeutic Cellular Depletion ‐ | |||||
| Platelet | 1 | EA | $ - 0 | |||
| 5082 | Therapeutic Plasma Exchange | 74 | EA | $ - 0 | ||
| 5083 | Red Cell Prime | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 | |||||
| REFERENCE TESTING | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 5084 | Radsure Label to be Irradiated | 1 | EA | $ - 0 | ||
| 5085 | Irradiation of Unit | 38 | EA | $ - 0 | ||
| 5086 | Deglycerolization of Unit | 1 | EA | $ - 0 | ||
| 5087 | Freeze Unit | 1 | EA | $ - 0 | ||
| 5088 | Freeze & Deglycerolization Unit | 1 | EA | $ - 0 | ||
| 5089 | Pooling unit(s) | 1 | EA | $ - 0 | ||
| 5090 | Thaw Unit | 1 | EA | $ - 0 | ||
| 5091 | RBC Wash | 1 | EA | $ - 0 | ||
| 5092 | Platelet Wash | 1 | EA | $ - 0 | ||
| 5093 | RBC Crossmatch (each additional unit) | 1 | EA | $ - 0 | ||
| 5094 | Non‐crossmatch set up | 1 | EA | $ - 0 | ||
| 5095 | ABO Group | 1 | EA | $ - 0 | ||
| 5096 | RH Type | 1 | EA | $ - 0 | ||
| 5097 | Chemical Treatment | 1 | EA | $ - 0 | ||
| 5098 | Aliquot Bag | 1 | EA | $ - 0 | ||
| 5099 | Confirmatory Draw | 1 | EA | $ - 0 | ||
| 5100 | Platelet (Volume Reduction Fee) | 1 | EA | $ - 0 | ||
| 5101 | Computer Antigen Search (per Antigen) | 1 | EA | $ - 0 | ||
| 5102 | Patient Complete Phenotype, Serologic | 1 | EA | $ - 0 | ||
| 5103 | Reconstitute | 1 | EA | $ - 0 | ||
| 5104 | RBC Antibody Identification | 30 | EA | $ - 0 | ||
| 5105 | Rare Unit | 5 | EA | $ - 0 | ||
| 5106 | Antigen Typing ‐ Single | 230 | EA | $ - 0 | ||
| 5107 | RBC Selected Cell Panel | 1 | EA | $ - 0 | ||
| 5108 | RBC Cell Separation | 1 | EA | $ - 0 | ||
| 5109 | IgG Dissociation | 1 | EA | $ - 0 | ||
| 5110 | Dithiotreitol Treatment | 1 | EA | $ - 0 | ||
| 5111 | Neutralization P1 or Lewis | 1 | EA | $ - 0 | ||
| 5112 | Chloroquine treatment | 1 | EA | $ - 0 | ||
| 5113 | Acid Elution / Cell Elution | 30 | EA | $ - 0 | ||
| 5114 | Donath‐Landsteiner Test | 1 | EA | $ - 0 | ||
| 5115 | Irradiation ‐ Per Random Platelet | 1 | EA | $ - 0 | ||
| 5116 | Rare Donor Search thru American Rare Donor Program (ARDP) | 1 | EA | $ - 0 | ||
| 5117 | Splitting Service | 1 | EA | $ - 0 | ||
| 5118 | Type and Screen | 30 | EA | $ - 0 | ||
| 5119 | ABO Group & Rh Type | 75 | EA | $ - 0 | ||
| 5120 | Antibody Screen (Indirect Coombs) | 15 | EA | $ - 0 | ||
| 5121 | RBC Antibody Titer | 1 | EA | $ - 0 | ||
| 5122 | Direct Antiglobulin IgG (Direct Coombs) | 63 | EA | $ - 0 | ||
| 5123 | Direct Antiglobulin DAT C3 | 1 | EA | $ - 0 | ||
| 5124 | Fetal Screen | 1 | EA | $ - 0 | ||
| 5125 | Kleihauer ‐ Betke | 1 | EA | $ - 0 | ||
| 5126 | CMV Test | 1 | EA | $ - 0 | ||
| 5127 | Sickle Cell Screen | 6 | EA | $ - 0 | ||
| 5128 | LUI Elution | 1 | EA | $ - 0 | ||
| 5129 | RBC Antibody Panel | 158 | EA | $ - 0 | ||
| 5130 | Transfusion Reaction Work Up | 5 | EA | $ - 0 | ||
| 5131 | RBC Antigen Typing | 32 | EA | $ - 0 | ||
| 5132 | Adsorption | 32 | EA | $ - 0 | ||
| 5133 | Cold Agglutinin Titer | 1 | EA | $ - 0 | ||
| 5134 | ABO RH Cord | 1 | EA | $ - 0 | ||
| 5135 | Sterile Doc Quad Pack | 1 | EA | $ - 0 | ||
| 5136 | Enzyme Treatment | 2 | EA | $ - 0 | ||
| 5137 | Lookback | 1 | EA | $ - 0 | ||
| 5138 | Crossmatch ‐ Electronic | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 | |||||
| OTHER TESTING | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 5139 | NAT (HIV ‐ I, HBV and HCV RNA) | |||||
| DONOR ONLY | 1 | EA | $ - 0 | |||
| 5140 | Non‐Donor Infectious Disease Markers 3327 | 1 | EA | $ - 0 | ||
| 5141 | Non‐Donor Infectious Disease Markers 3486, no ABO/Rh | 1 | EA | $ - 0 | ||
| 5142 | White Blood Cell Counts by Flow Cytometry | 1 | EA | $ - 0 | ||
| 5143 | Cryoprecipitate QC | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 |
| TOTAL | $ - 0 | |
| Total contract value including option years | $ - 0 |
Gainesville
| ATTACHMENT A: PRICE/COST SCHEDULE - GAINESVILLE | ||||||
| North Florida/South Gerogia VA Health System, 1601 S.W. Archer Road, Gainsville, FL 32608 | ||||||
| BASE PERIOD (Estimated Delivery date January 1, 2019 - September 30, 2019 | ||||||
| BLOOD COMPONENTS | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Est Unit Price | Estimated Total Price | |
| 0001 | Whole Blood Leukoreduced | 1 | EA | $ - 0 | ||
| 0002 | Whole Blood Leukoreduced Low | |||||
| Volume | 1 | EA | $ - 0 | |||
| 0003 | Whole Blood Leukoreduced Low | |||||
| Volume Irradiated | 1 | EA | $ - 0 | |||
| 0004 | Whole Blood Autologous | |||||
| Leukoreduced | 1 | EA | $ - 0 | |||
| 0005 | Red Blood Cells Leukoreduced | 3338 | EA | $ - 0 | ||
| 0006 | Red Blood Cells Leukoreduced | |||||
| Deglycerolized | 1 | EA | $ - 0 | |||
| 0007 | Red Blood Cells Leukoreduced Frozen | 1 | EA | $ - 0 | ||
| 0008 | Red Blood Cells Leukoreduced | |||||
| Irradiated | 1 | EA | $ - 0 | |||
| 0009 | Red Blood Cells Leukoreduced Low | |||||
| Volume | 1 | EA | $ - 0 | |||
| 0010 | Red Blood Cells Leukoreduced Washed | 1 | EA | $ - 0 | ||
| 0011 | Red Blood Cells Leukoreduced | |||||
| Deglycerolized Irradiated | 1 | EA | $ - 0 | |||
| 0012 | Red Blood Cells Leukoreduced | |||||
| Irradiated Washed | 1 | EA | $ - 0 | |||
| 0013 | Red Blood Cells Leukoreduced Processing ‐ Infant (PediCells ‐ CMV | |||||
| Neg.,) | 1 | EA | $ - 0 | |||
| 0014 | Red Blood Cells Autologous | |||||
| Leukoreduced | 1 | EA | $ - 0 | |||
| 0015 | Red Blood Cells Autologous | |||||
| Leukoreduced Deglycerolized | 1 | EA | $ - 0 | |||
| 0016 | Whole Blood Platelets Leukoreduced | 1 | EA | $ - 0 | ||
| 0017 | Platelet Pheresis Pedi‐D | 1 | EA | $ - 0 | ||
| 0018 | Platelet Pheresis Pedi‐W | 1 | EA | $ - 0 | ||
| 0019 | Cryoprecipitate | 1 | EA | $ - 0 | ||
| 0020 | Pooled Cryoprecipitate (5) | 1 | EA | $ - 0 | ||
| 0021 | Pooled Cryoprecipitate (10) | 50 | EA | $ - 0 | ||
| 0022 | Fresh Frozen Plasma | 306 | EA | $ - 0 | ||
| 0023 | Fresh Frozen Plasma Cryo‐removed | 1 | EA | $ - 0 | ||
| 0024 | Fresh Frozen Plasma 0‐24 | 1 | EA | $ - 0 | ||
| 0025 | Fresh Frozen Plasma ‐ Infant Dose | |||||
| (Pediplasma Processing) | 1 | EA | $ - 0 | |||
| 0026 | Neo‐Natal Fresh Frozen Plasma | 1 | EA | $ - 0 | ||
| 0027 | Plasma (Liquid) | 1 | EA | $ - 0 | ||
| 0028 | Plasma (Liquid) Irradiated | 1 | EA | $ - 0 | ||
| 0029 | Source Leukocyte | 1 | EA | $ - 0 | ||
| 0030 | Apheresis Platelets (SDP) | |||||
| Leukoreduced | 652 | EA | $ - 0 | |||
| 0031 | Apheresis Platelets (SDP) | |||||
| Leukoreduced Irradiated | 1 | EA | $ - 0 | |||
| 0032 | Apheresis Platelets (SDP) | |||||
| Leukoreduced Low Volume | 1 | EA | $ - 0 | |||
| 0033 | Apheresis Platelets (SDP)/LIW Leukoreduced Irradiated Washed | 1 | EA | $ - 0 | ||
| 0034 | Apheresis Platelets (SDP) | |||||
| Leukoreduced Low Volume Irradiated | 1 | EA | $ - 0 | |||
| 0035 | Apheresis Platelets (SDP) Autologous | |||||
| Leukoreduced Irradiated | 1 | EA | $ - 0 | |||
| 0036 | Apheresis Granulocytes | 1 | EA | $ - 0 | ||
| 0037 | Apheresis Granulocytes Irradiated | 1 | EA | $ - 0 | ||
| 0038 | Pooled Platelets Leukoreduced | 1 | EA | $ - 0 | ||
| 0039 | Pooled Platelets Leukoreduced | |||||
| Irradiated | 1 | EA | $ - 0 | |||
| SUBTOTAL | $ - 0 | |||||
| CELLULAR LAB | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 0040 | SC ABO Incompatible Buffy Coat Enrichment | 1 | EA | $ - 0 | ||
| 0041 | SC Plasma Depletion | 1 | EA | $ - 0 | ||
| 0042 | SC Cryopreservation (includes 1st year storage) | 1 | EA | $ - 0 | ||
| 0043 | SC Colony Forming Unit (CFU) | 1 | EA | $ - 0 | ||
| 0044 | SC Stem Cell Quality Control | 1 | EA | $ - 0 | ||
| 0045 | SC Cord Wash Process | 1 | EA | $ - 0 | ||
| 0046 | SC Cord Blood Reconstitution | 1 | EA | $ - 0 | ||
| 0047 | Stem Cell Freight | 1 | EA | $ - 0 | ||
| 0048 | SC Thawing Frozen Cell (QC Vial ea) | 1 | EA | $ - 0 | ||
| 0049 | SC CBC with automated differential | 1 | EA | $ - 0 | ||
| 0050 | SC CBC with manual differential | 1 | EA | $ - 0 | ||
| 0051 | CD34 Test | 1 | EA | $ - 0 | ||
| 0052 | SC Cellular Night and Weekend Fee | 1 | EA | $ - 0 | ||
| 0053 | SC Trypan Blue viability | 1 | EA | $ - 0 | ||
| 0054 | SC Storage greater than 1 year (storage per year) | 1 | EA | $ - 0 | ||
| 0055 | SC Sterility Check | 1 | EA | $ - 0 | ||
| 0056 | SC CD3 | 1 | EA | $ - 0 | ||
| 0057 | SC CD4 | 1 | EA | $ - 0 | ||
| 0058 | SC CD8 | 1 | EA | $ - 0 | ||
| 0059 | SC Processing Split Exceeding 4 Bags (each) | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 | |||||
| HLA AND SPECIAL HEMATOLOGY TESTING | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 0060 | Platelet Crossmatch | 1 | EA | $ - 0 | ||
| 0061 | HLA/Platelet Antibody Screen (Serology/ELISA) | 1 | EA | $ - 0 | ||
| 0062 | HLA‐Antibody Intermediate Resolution, Complex | 1 | EA | $ - 0 |
This is the start of the file's text. The full file is on GovTribe.
File details come from the government source that posted it. Updated .